Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Incyte reports encouraging topline phase IIb results for INCB-18424 in psoriasis

Sep. 22, 2009

LEO-29102 cream evaluated in healthy and psoriatic subjects in phase I and II trials

Sep. 22, 2009

PH-10 aqueous hydrogel to be assessed in plaque psoriasis in phase II trial

Sep. 14, 2009

Phase I/II study to determine safety/efficacy of KP-413 in atopic dermatitis

Sep. 10, 2009

Can-Fite BioPharma reports results from its phase II CF-101 trial in psoriasis

Sep. 9, 2009

Rohto discovers alpha-MSH inhibitors for the treatment of dermatological disorders

Sep. 8, 2009

Peplin to be acquired by Leo Pharma for USD 287.5 million in cash

Sep. 4, 2009

Clinuvel receives European approval to initiate phase III trial of afamelanotide in EPP

Sep. 1, 2009

Morria obtains clearance to conduct phase II MRX-6 study for contact dermatitis

Aug. 27, 2009

Wisconsin Alumni Research Foundation describes VDR ligands for skin conditions

Aug. 26, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...